Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The millennials are investing in VBIO. Just who we want to invest. https://www.tritonfunds.com/
For them not saying anything for 2 years this investor letter says a lot and makes sense.
I like the Final Thoughts
The past two years have presented a number of challenges – and opportunities – for our officers, directors, employees and shareholders. Our entire team has worked tirelessly to navigate through these challenges, capitalize on opportunities, and execute our corporate recovery plan in order to reposition Vitality for future success. On behalf of our officers and directors, I would like to express our gratitude to each Vitality shareholder for your patience and support of our efforts. Our team still has a lot more work to do but we are highly motivated and confident that better days are ahead for Vitality and its shareholders.
Hopefully they have some good news up their sleeve after the name change.
They seem very confident.
Sundial Master Grower!!! https://www.growopportunity.ca/plant-artist/
This company is a biopharma ETF in itself unbelievable! Been accumulatiing.
Hopefully the new management will concentrate on one thing getting VBX 100 into the clinic. The reason well all bought the stock. A deal with and established Pharma would be best.
There are 9 million reasons for Vitality to show life and the people who invested are very active in taking the company to the next level.
New 8K
Investors settled with company got another 16,750000 shares warrants erased.
So basically they financed the company at 40 cents a share.
Because of SEC debacle
Two of the investors joined the board. One as chairman one as a director 8 days after the sec announcement.
Does not make sense for them do to that if they were not all in.
Its been 2 and a half months since and not one lawsuit.
Here is a quote from one of the major players in the financing deal after the SEC debacle
.I have great confidence in the vision and talent of the Vitality team,” commented Mr. Feighan, “and I believe Vitality is at the forefront of a major new industry providing cannabinoid-based medical solutions.”
They build the molecules at the Yuba City Lab.
The registration investigation from 2016 has been completed in writing from SEC.
It also looks like the company has provided the information the SEC needs for trading again.
We will trade on the gray for at least 30 days.
From OTC web site
When Does Caveat Emptor Get Removed?
Facts and circumstances may differ, however generally, OTC Markets Group will remove the Caveat Emptor designation once the company meets the qualifications for Pink Current Information, has verified the information on its company profile on www.otcmarkets.com, and demonstrates that there is no longer a public interest concern. The Caveat Emptor designation is typically not removed within the first 30 days. During the time it is labeled Caveat Emptor, any stock that is not in Pink Current Information will also have its quotes blocked on www.otcmarkets.com.
The company also did disclose recent market activity to the OTC on 8/2018 and 6/2018https://www.otcmarkets.com/stock/VBIO/news
Insiders have never sold any stock.
Otc markets have new info on there web site as of yesterday on hare structure.https://www.otcmarkets.com/stock/VBIO/security
You probably are correct about that.
Why would they join the board if they were taking the money back?
I really Doubt that. The guys just elected to the board are part of the group that invested.
Im sure their not. I think they made a commitment to see this through clinical trials.
The company has the money now they should start getting things done.
Lucky they got financed before the sec thing. :)
Company added 2 board of directors with skin in the game.https://www.sec.gov/Archives/edgar/data/1438943/000149315218016296/form8-k.htm
I would say not this document was filed 10/02/2018.
If you look at the table on page 25 VBIO is dated at 6/3/2015.
The stock symbol VBIO did not exist until 8/17/2016
Vitality has the Primo spot for presentation at CannMed conferencehttp://www.cannmedevents.com/schedule/
You are correct Brandon Zipp is very smart so is Robert Brook and Janee' Hardman.
They all have their names on the Patent as inventors.
Here is the patent again!https://patents.google.com/patent/WO2017053574A1/en
CannMed Medical conference on October 23 should be a major event for the company.
This is not a investor conference but a conference about the science. Vitality has the science and
the people there understand the science.
Vitality is the only company showcasing a new drug If you read about all the presenters.
Will be very exciting!!!
File with the FDA for clinical trials in humans.
They just financed again.
Small financing of 333,334 shares for $500,000 $1.50 a share looks like no fees again.
166,667 in warrants at $2.00 a share
This should take them through until they file with FDA.
Just warming up the engines!!!
Here is the Vitality Patent. Check it out.
https://patents.google.com/patent/WO2017053574A1/en
I also accumulated a lot of those cheap shares!!
They are working on it. They want the whole program it will be worth the wait!
Green light from FDA will propel this to $5.00 very quickly.
I'm still accumulating at these low prices.
They are grinding out the IND.
http://zippypickle.com/wp/
Here is a new article from Brandon Zipp, zippy pickle.com web site.
This will tell you what this company is about
http://zippypickle.com/wp/2018/01/28/the-grind/
Patent filing.lol
Odds are Good. This company is Very Thorough when they file something.
Just read through there patient filing. IND will also be coming up.
Latest letter from sec on there september S-1 filing.
You can look it up yourself. If they had a problem the SEC would not send this letter.
https://www.sec.gov/Archives/edgar/data/1438943/000000000017035911/0000000000-17-035911-index.htm Mail Stop 3561
Via E-mail
Robert Brooke
Chief Executive Officer
Vitality Biopharma, Inc.
1901 Avenue of the Stars, 2nd Floor Los Angeles, California 90067
Re: Vitality Biopharma, Inc. Registration Statement on Form S-1 FiledSeptember13,2017
File No. 333-220446
Dear Mr. Brooke:
October 10, 2017
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Michael Killoy at (202) 551-7576 with any questions.
cc: Mark C. Lee, Esq. Greenberg Traurig, LLP
Sincerely,
/s/ James Lopez (for)
John Reynolds
Assistant Director
Office of Beverages, Apparel, and Mining
They have 7 employees 2Phd, 4 masters and a financial guy.
Young smart people on a mission doing it very frugal. They know they discovered a process of great value.
Even the way they raise money is not seen ever in these little companies. Just raised 1.4 million and only paid 5000 in fees. unheard of!!!
Their working on a IND Investigational New Drug app.The FDA has 30 days to comment, if they don't clinical trials on humans can begin.
They must be close since they filed for orphan designation i would think it would be similar data they need to provide.
Ill just keep accumulating at these ridiculous low stock prices.